SIR-Spheres® Y-90 resin microspheres
Programs
Sirtex has developed key tools to help physicians significantly reduce patient wait time. When these tools are implemented, patients will receive focused care, allowing the quickest time to treatment.
SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of:
- Unresectable hepatocellular carcinoma (HCC), or
- Unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy, or
- Unresectable intrahepatic cholangiocarcinoma (iCCA), or
- Hepatic metastases by neuroendocrine tumours (mNET), or
- Other liver metastases